Skip Navigation

Sarepta soars as FDA delays review of key drug

In this video

SRPT

Halftime Report

Sarepta soars as FDA delays review of key drug

CNBC's Dominic Chu reports on Sarepta Therapeutics and its Duchenne muscular dystrophy drug trial. The "FMHR" traders weigh in on the trade.

03:42

Wed, May 25 201612:15 PM EDT

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

FAA probing Boeing 787 inspections to find out if employees falsified records

FAA probing Boeing 787 inspections to find out if employees falsified records

Hightower's Stephanie Link doesn't expect a Fed cut this year

Hightower's Stephanie Link doesn't expect a Fed cut this year

Food startup uses AI to cut food waste

Food startup uses AI to cut food waste

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Sen. Joe Manchin: The U.S. needs supply chain it can rely on with 'our allies not our adversaries'

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

Social Security trust fund set to be depleted by 2035 estimates U.S. Treasury

FAA probing Boeing 787 inspections to find out if employees falsified records

FAA probing Boeing 787 inspections to find out if employees falsified records

Hightower's Stephanie Link doesn't expect a Fed cut this year

Hightower's Stephanie Link doesn't expect a Fed cut this year

Food startup uses AI to cut food waste

Food startup uses AI to cut food waste